Melittin Inhibits Ovarian Cancer Cell Growth by Downregulating MMP9 Expression via the JAK2-STAT3 Signaling Pathway
Melittin may inhibit the growth of ovarian cancer cells by downregulating MMP9 expression via the JAK2-STAT3 signaling pathway, thus exerting a therapeutic effect.
Authors
- Danying Zhang
- Shuai Sun
- Chaoqin Yu (ORCID: https://orcid.org/0000-0003-1614-2655)
- Jin Yu
- Hao Ji (ORCID: https://orcid.org/0000-0003-1513-9884)
- Yujia Jiang
- Huimin Sun (ORCID: https://orcid.org/0000-0002-2892-5596)
- Jing Zhou (ORCID: https://orcid.org/0009-0004-6586-0762)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2025-04-29
- DOI
- https://doi.org/10.2174/0109298673355946250403071132
- Citations
- 2
- Primary Topic
- Healthcare and Venom Research
- Type
- article
- Field-Weighted Citation Impact
- 2.79